Kemwell Biopharma, a contract development and manufacturing service provider, announced today that it has manufactured and supplied drug substance using its state-of-the-art mammalian cell culture plant in India for clinical trials that will be performed by its customer in USA for an IND filing. The customer has received IND approval and is commencing Phase 1 clinical trials.…